4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 706-715

  Oh, Ju Hoon ^a   Ban, Jung Ok ^a   Cho, Min Chul ^a   Jo, Miran ^a   Jung, Jae Kyung ^a   Ahn, Byeongwoo ^a   Yoon, Do Young ^b   Han, Sang Bae ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

4 O methylhonokiol; Cancer cells; Growth inhibition; NF B; P21

Indexed keywords

4 O METHYLHONOKIOL; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAGNOLIA OFFICINALIS EXTRACT; PROTEIN P21; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER INHIBITION; CELL CYCLE G0 PHASE; COLON TUMOR; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BIPHENYL COMPOUNDS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HUMANS; LIGNANS; MAGNOLIA; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; PLANT EXTRACTS; RNA, SMALL INTERFERING;

MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MUS MUSCULUS;

EID: 84862328322     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.013     Document Type: Article

References (46)

1. Shigemura K., Arbiser J.L., Sun S.Y., Zayzafoon M., Johnstone P.A., Fujisawa M., et al. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 2007, 109:1279-1289.
2. Seo J.J., Lee S.H., Lee Y.S., Kwon B.M., Ma Y., Hwang B.Y., et al. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog. Neuropsychopharmacol Biol Psychiatry 2007, 31:1363-1369.
3. Fried L.E., Arbiser J.L. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 2009, 11:1139-1148.
4. Wang T., Chen F., Chen Z., Wu Y.F., Xu X.L., Zheng S., et al. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 2004, 10:2205-2208.
5. Hahm E.R., Arlotti J.A., Marynowski S.W., Singh S.V. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008, 14:1248-1257.
6. Yang S.E., Hsieh M.T., Tsai T.H., Hsu S.L. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 2002, 63:1641-1651.
7. Wolf I., O'Kelly J., Wakimoto N., Nguyen A., Amblard F., Karlan B.Y., et al. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 2007, 30:1529-1537.
8. Lee D.H., Szczepanski M.J., Lee Y.J. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 2009, 106:1113-1122.
9. Lin S.Y., Liu J.D., Chang H.C., Yeh S.D., Lin C.H., Lee W.S. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem 2002, 84:532-544.
10. Lee S.Y., Yuk D.Y., Song H.S., Yoon do Y., Jung J.K., Moon D.C., et al. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB. Eur J Pharmacol 2008, 582:17-25.
11. Richmond A. NF-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2008, 2:664-674.
12. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
13. Dolcet X., Llobet D., Pallares J., Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch 2005, 446:475-482.
14. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
15. Suh J., Rabson A.B. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?. J Cell Biochem 2004, 91:100-117.
16. Lind D.S., Hochwald S.N., Malaty J., Rekkas S., Hebig P., Mishra G., et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 2001, 130:363-369.
17. Garg A., Aggarwal B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002, 16:1053-1068.
18. Allen C.T., Ricker J.L., Chen Z., Van Waes C. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007, 29:959-971.
19. Lee J.H., Koo T.H., Hwang B.Y., Lee J.J. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 2002, 277:18411-18420.
20. Lee J.H., Hwang B.Y., Kim K.S., Nam J.B., Hong Y.S., Lee J.J. Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis. Biochem Pharmacol 2003, 66:1925-1933.
21. Chen L., Zhang H.Y. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007, 12:946-957.
22. Ban J.O., Lee H.S., Jeong H.S., Song S., Hwang B.Y., Moon D.C., et al. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. Mol Cancer Res 2009, 7:870-879.
23. Ban J.O., Oh J.H., Hwang B.Y., Moon D.C., Jeong H.S., Lee S., et al. Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50. Mol Cancer Ther 2009, 8:1613-1624.
24. Son D.J., Park M.H., Chae S.J., Moon S.O., Lee J.W., Song H.S., et al. Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther 2007, 6:675-683.
25. Biggs J.R., Kraft A.S. Inhibitors of cyclin-dependent kinase and cancer. J Mol Med 1995, 73:509-514.
26. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008, 28:2167-2174.
27. Hellin A.C., Bentires-Alj M., Verlaet M., Benoit V., Gielen J., Bours V., et al. Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis. J Pharmacol Exp Ther 2007, 295:870-878.
28. Chang P.Y., Miyamoto S. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells. Mol Cancer Res 2006, 4:101-112.
29. Lee S.J., Kim H.M., Cho Y.H., Park K., Kim E.J., Jung K.H., et al. Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase. Oncol Rep 2007, 18:729-736.
30. Oh J.H., Kang L.L., Ban J.O., Kim Y.H., Kim K.H., Han S.B., et al. Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-kappaB. Chem Biol Interact 2009, 180:506-514.
31. Rey M.J., Fernández P.L., Jares P., Muñoz M., Nadal A., Peiró N., et al. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J Pathol 1998, 184:265-271.
32. Chen J., Saha P., Kornbluth S., Dynlacht B.D., Dutta A. Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell. Biol 1996, 16:4673-4682.
33. Funk J.O., Waga S., Harry J.B., Espling E., Stillman B., Galloway D.A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 1997, 11:2090-2100.
34. Mackenzie G.G., Queisser N., Wolfson M.L., Fraga C.G., Adamo A.M., Oteiza P.I. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer 2008, 123:56-65.
35. Machijima Y., Ishikawa C., Sawada S., Okudaira T., Uchihara J.N., Tanaka Y., et al. Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol. Retrovirology 2009, 16:6-7.
36. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995, 6:387-400.
37. Hahm E.R., Singh S.V. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 2007, 6:2686-2695.
38. Benoit V., de Moraes E., Dar N.A., Taranchon E., Bours V., Hautefeuille A., et al. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene 2006, 25:5708-5718.
39. Meylan E., Dooley A.L., Feldser D.M., Shen L., Turk E., Ouyang C., et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009, 462:104-107.
40. Yamada K., Moriyama H., Yasuda H., Hara K., Maniwa Y., Hamada H., et al. Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity. Hum Gene Ther 2007, 18:389-400.
41. Park K., Choi K., Kim H., Kim K., Lee M.H., Lee J.H., et al. Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis. Exp Mol Med 2009, 41:371-381.
42. Chiu T.L., Su C.C. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Int J Mol Med 2009, 23:469-475.
43. Lin Y.J., Huang Y.H., Zhen Y.Z., Liu X.J., Zhen Y.S. Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway. Yao Xue Xue Bao 2008, 43:1099-1105.
44. Chen F., Wang T., Wu Y.F., Gu Y., Xu X.L., Zheng S., et al. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004, 10:3459-3463.
45. Hu J., Chen L.J., Liu L., Chen X., Chen P.L., Yang G., et al. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med 2008, 40:617-628.
46. Liu Z., Zhang X., Cui W., Zhang X., Li N., Chen J., et al. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul Toxicol Pharmacol 2007, 9:160-171.